An audit of the State Cannabis Control Control Council has found the violations and procedural differences in state regulations, attributed to the regulation of the Cannabis Industry of Massachusetts, Diana DiscoGlio’s office said on Thursday.
The review, the Commission reviewed the Committee of Committees 2022 to 2024, mentioned regulatory translators. The agency determined that the regulations did not properly enforce or gather concerns about transparency and fairness and could not administer the license extension fees caused by loss of income.
The audit revealed “the appearance of potential froitism” “as some Cannabis business had to pay fees,” others did not have to do that, “said the office.
“CCC management failed to take appropriate steps and taking institute procedures, fully quantifying and accurately managed licensing extensions,” the statement said. “Licensed members and minimum responsibilities Licensed members took advantage of the demands of demands and homologations.”
USDA’s Animal and Plant Health Inspection Service (APHIS) recently issued regulatory status review responses for two new gene-edited hemp varieties, determining that they are not subject to federal regulation under 7 CFR part 340. Developed by researchers at the University of Wisconsin-Madison, these gene-edited plants have been found to have no increased risk of plant pests compared to conventional hemp. This federal clearance marks an important milestone in easing the path from laboratory to commercial cultivation of precision-bred industrial crops.
Badger PMR (Dust Resistant) has full dust resistance, and Badger Zero (Cannabinoid Free) is cannabinoid free. The main innovation involves the creation of hemp varieties that are unable to produce THC (tetrahydrocannabinol), the psychoactive compound found in cannabis. Using CRISPR gene-editing technology to turn off specific genes responsible for THC production, the UW-Madison team has solved a major hurdle for the industry. This genetic certainty prevents crops from being “hot” — the term used when THC levels accidentally exceed the legal limit of 0.3 percent — which previously forced farmers to destroy entire fields to comply with federal law.
Beyond THC removal, researchers have also engineered varieties with higher concentrations of CBG (cannabigerol), a non-psychoactive cannabinoid valued for its potential therapeutic benefits. These advances are expected to stabilize the hemp market, providing growers with reliable, high-value and legal-compliant varieties. With the regulatory green light from the USDA, these precision-bred hemp lines are poised to revitalize the industry, providing a safer and more profitable future for farmers across the United States.
For more information: International Service for the Acquisition of Agricultural Biotechnology Applications Email: (email protected) isaaa.org/default.asp
Kentucky’s governor is urging lawmakers to give more patients legal access to medical marijuana, announcing that cannabis gummies can now be purchased at state-licensed dispensaries.
Gov. Andy Beshear (D) said Thursday that his administration has sent a letter urging legislative leadership to pass a bill that lists ALS, Parkinson’s disease, Crohn’s disease, sickle cell anemia, fibromyalgia, glaucoma, terminal illnesses and other conditions as conditions for medical cannabis.
“In most other states that have a medical marijuana program, these are conditions that are covered, and conditions that are deemed appropriate by our board of physicians and counselors,” he said. “Expanding the list could help the approximately 430,000 Kentuckians who currently lack access but face these challenges.”
The governor said state officials are “making great strides” in expanding the medical marijuana program to “increase access for those who are already eligible.”
“We currently have 510 registered professionals and over 18,500 approved cards, and those numbers continue to grow,” Beshear said, adding that regulators are making “steady progress” in accepting businesses at every step of the cannabis supply chain.
“As the supply chain expands, patients are starting to see more options online,” he said. “We can announce that gummies are on the market in Kentucky and showing progress in communities across Kentucky.”
The governor, who has long championed cannabis reform, he anticipated a market launch that monthwhile claiming that medical marijuana will help thousands of patients find an alternative to opioids for pain management.
Beshear previously acknowledged that “it’s taken longer than we would have liked” to sustain the industry since he signed off on legalizing medical marijuana in 2023.
Beshear announced separately that in May the state launched a new online directory that allows people to see where medicinal cannabis will open next to them
Meanwhile, the governors sent a letter to Kentucky’s congressional delegation last yearurging them to “take decisive action to protect the constitutional rights of our law-abiding medical cannabis patients” by repealing the federal ban on possession of firearms by marijuana users.
The federal Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) warned Kentucky residents that in 2024, if they choose to participate in the state’s medical marijuana program, they will be prohibited from buying or possessing firearms under federal law.
Marihuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.
Oklahoma Governor Kevin Stitt he said He wants to return the state’s medical marijuana program to voters. In his State of the State address, Stitt called for a state question in 2026 for citizens to decide whether to end the program, citing concerns about “bad actors” and criminal influence.
Dispensary owner Dana Herrick he reacted to the adHe noted that in 2018 medical cannabis was approved by voters. Herrick said the program gave patients access to drugs and raised questions about what returning the issue to a public vote would mean for existing companies.
The state’s medical cannabis system has grown since 2018. The Oklahoma Medical Marijuana Authority oversees growers, processors and dispensaries with more than 1,500 active licenses. Regulators have implemented measures such as credential checks and a temporary moratorium on new licenses to manage the industry’s growth.